Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.

Source:http://linkedlifedata.com/resource/pubmed/id/2242534

Download in:

View as

General Info

PMID
2242534